 |
 |

Diabetes and Glaucoma
Michael A. Kass, MD;
Mae O. Gordon, PhD; for the Ocular Hypertension Treatment Study Group
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Dr Sommer1 reminds us that associations found in large data sets may not be correct or causally related. He also points out the need for common sense when interpreting data from clinical trials or epidemiologic studies. He believes that investigators of the Ocular Hypertension Treatment Study (OHTS) may not have followed these admonitions.
One of the major goals of the OHTS was to understand the factors associated with the development of primary open-angle glaucoma (POAG) in individuals with ocular hypertension.2 There is an extensive literature on diabetes mellitus and the risk of POAG. Unfortunately, the literature is contradictory, and it is difficult to draw conclusions about this association. Therefore, we thought it was important to assess this association in the OHTS. In our initial analysis published in 2002,3 we used patient self-report of diabetes. Dr . . . [Full Text of this Article] AUTHOR INFORMATION
RELATED LETTER
Misclassification: Who Really Lives in This Neighborhood?
Alfred Sommer
Arch Ophthalmol. 2008;126(2):265-266.
EXTRACT
| FULL TEXT
RELATED ARTICLES
Is a History of Diabetes Mellitus Protective Against Developing Primary Open-angle Glaucoma?
Mae O. Gordon, Julia A. Beiser, Michael A. Kass, and for the Ocular Hypertension Treatment Study Group
Arch Ophthalmol. 2008;126(2):280-281.
EXTRACT
| FULL TEXT
The Ocular Hypertension Treatment Study: Baseline Factors That Predict the Onset of Primary Open-Angle Glaucoma
Mae O. Gordon, Julia A. Beiser, James D. Brandt, Dale K. Heuer, Eve J. Higginbotham, Chris A. Johnson, John L. Keltner, J. Philip Miller, Richard K. Parrish II, M. Roy Wilson, Michael A. Kass, and for the Ocular Hypertension Treatment Study Group
Arch Ophthalmol. 2002;120(6):714-720.
ABSTRACT
| FULL TEXT
The Ocular Hypertension Treatment Study: Design and Baseline Description of the Participants
Mae O. Gordon, Michael A. Kass, and for the Ocular Hypertension Treatment Study Group
Arch Ophthalmol. 1999;117(5):573-583.
ABSTRACT
| FULL TEXT
|